Study guide
8.2 Anxiety Disorders, OCD, PTSD, & Somatic Symptom Disorders
Medical Council of Canada Qualifying Examination Part I MCCQE Part I
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Overview, Blueprint & Canadian Medical Practice
1.1 MCCQE Part I Format, Scoring (439 Scale), & Strategy 1.2 The MCC Blueprint Matrix: Dimensions of Care & Physician Activities 1.3 Canadian Healthcare System, CanMEDS Roles, & Interprofessional Care 1.4 Evidence-Based Medicine, Study Design, & Clinical Statistics
2 Chapter 2: Population Health, Health Promotion & Preventive Care
2.1 Canadian Task Force on Preventive Health Care (CTFPHC) Screening Guidelines 2.2 Immunization Schedules (NACI) & Vaccine-Preventable Diseases across Lifespan 2.3 Disease Prevention, Lifestyle Counselling, & Harm Reduction 2.4 Outbreak Management, Disease Surveillance, & Infection Control 2.5 Occupational, Environmental, & Travel Medicine in Canada
3 Chapter 3: Internal Medicine — Cardiovascular & Respiratory Systems
3.1 Hypertension Canada 2020/2025 Guidelines, Dyslipidemia, & Primary Prevention 3.2 Ischemic Heart Disease, Acute Coronary Syndromes, & Heart Failure Management 3.3 Arrhythmias, Valvular Heart Disease, & Infective Endocarditis 3.4 Asthma, COPD, & Respiratory Failure (CTS Guidelines) 3.5 Thromboembolic Disease (DVT/PE), Pneumonia, & Pleural Effusions
4 Chapter 4: Internal Medicine — GI, Endocrine, Renal & Hematology/Oncology
4.1 Gastrointestinal Disorders, Acute Abdomen, & Liver/Biliary Disease 4.2 Diabetes Canada 2020/2025 Guidelines & Glycemic Management 4.3 Thyroid, Adrenal, Pituitary, & Electrolyte Disturbances 4.4 Acute Kidney Injury (AKI), Chronic Kidney Disease (CKD), & Nephrology 4.5 Hematology, Anemia Evaluation, Transfusion Medicine, & Common Cancers
5 Chapter 5: General Surgery, Orthopedics, & Emergency Care
5.1 Surgical Evaluation, Preoperative Clearance, & Postoperative Complications 5.2 Trauma Management (ATLS Protocol) & Burns 5.3 Acute Surgical Conditions (Appendicitis, Cholecystitis, Bowel Obstruction) 5.4 Fractures, Dislocations, Joint Pain, & Musculoskeletal Emergencies 5.5 Vascular Emergencies, Wound Care, & Shock Recognition
6 Chapter 6: Pediatrics & Adolescent Health
6.1 Pediatric Growth, Developmental Milestones, & Well-Child Examinations 6.2 Neonatal Resuscitation, Jaundice, & Common Congenital Anomalies 6.3 Pediatric Respiratory Emergencies (Croup, Bronchiolitis, Asthma) 6.4 Common Pediatric Infections, Exanthems, & Fever of Unknown Origin 6.5 Pediatric Abdominal Pain, Dehydration, & Fluid Management
7 Chapter 7: Obstetrics & Gynecology
7.1 Routine Antepartum Care, Screening, & Prenatal Diagnosis (SOGC Guidelines) 7.2 Medical Complications of Pregnancy (Preeclampsia, Gestational Diabetes, Infections) 7.3 Labor, Intrapartum Management, & Postpartum Complications/Hemorrhage 7.4 Abnormal Uterine Bleeding, Gynecologic Infections, & Contraception/Menopause 7.5 Gynecologic Oncology & Pelvic Mass Evaluation
8 Chapter 8: Psychiatry & Mental Health
8.1 Mood Disorders (Depression, Bipolar) & Suicide Risk Assessment 8.2 Anxiety Disorders, OCD, PTSD, & Somatic Symptom Disorders 8.3 Psychotic Disorders & Schizophrenia Management 8.4 Substance Use Disorders, Withdrawal Syndromes, & Harm Reduction 8.5 Pediatric, Perinatal, & Geriatric Psychiatry (Cognitive Impairment / Delirium)
9 Chapter 9: Neurology, Rheumatology, & Dermatology
9.1 Acute Stroke, TIA, & Neurovascular Emergencies 9.2 Headaches, Seizures, Movement Disorders, & Neuromuscular Disease 9.3 Inflammatory Arthritides (RA, Gout, SpA) & Systemic Autoimmune Diseases (SLE, Vasculitis) 9.4 Common Dermatologic Conditions, Cutaneous Manifestations of Systemic Disease, & Skin Cancers 9.5 Musculoskeletal Soft Tissue Injuries, Back Pain, & Physical Medicine
10 Chapter 10: Legal, Ethical, & Professional Behaviours in Canadian Practice
10.1 Informed Consent, Capacity Assessment, & Substitute Decision-Making (CMPA) 10.2 Medical Confidentiality, Privacy Laws (PIPEDA/PHIPA), & Disclosure of Harm 10.3 CMA Code of Ethics, Professionalism, & Physician Health/Boundary Issues 10.4 Mandatory Reporting (Child/Elder Abuse, Driving Safety, Fitness to Practice) & Quality/Safety
8.2 Anxiety Disorders, OCD, PTSD, & Somatic Symptom Disorders
Key Takeaways Explain This Topic AI
First-line pharmacotherapy for GAD, Panic Disorder, and Social Anxiety Disorder consists of SSRIs or SNRIs combined with Cognitive Behavioral Therapy (CBT); benzodiazepines are reserved for short-term acute rescue only.
Obsessive-Compulsive Disorder (OCD) requires Exposure and Response Prevention (ERP) behavioral therapy alongside high-dose SSRI therapy or clomipramine.
Post-Traumatic Stress Disorder (PTSD) diagnosis requires symptoms >1 month across four clusters (intrusion, avoidance, negative mood/cognitions, hyperarousal); prazosin is first-line for PTSD-associated nightmares.
Somatic Symptom Disorder involves excessive anxiety and persistent thoughts regarding real bodily symptoms, whereas Illness Anxiety Disorder involves fear of having a serious illness with minimal or absent physical symptoms.
Conversion Disorder (Functional Neurological Symptom Disorder) presents with genuine neurological deficits (e.g., non-epileptic seizures, weakness) incompatible with recognized neuroanatomy, requiring empathetic validation without confronting symptoms as fake.
Last updated: July 2026
8.2 Anxiety Disorders, OCD, PTSD, & Somatic Symptom Disorders
Anxiety, obsessive-compulsive, trauma-related, and somatic symptom disorders represent a broad spectrum of psychiatric conditions frequently encountered in primary care. Accurate diagnosis requires distinguishing between normal adaptive anxiety, discrete anxiety syndromes, trauma-related pathology, and physical complaints driven by psychological distress.
- Anxiety Disorders Spectrum
- Clinical Features & Diagnostic Distinctions
Generalized Anxiety Disorder (GAD): Excessive, uncontrollable worry about multiple everyday events occurring for at least 6 months , accompanied by ≥ 3 \ge 3 ≥ 3 physical symptoms (restlessness, fatigue, concentration difficulty, irritability, muscle tension, sleep disturbance).
Panic Disorder: Recurrent, unexpected panic attacks (abrupt surges of intense fear reaching a peak within minutes) followed by at least 1 month of persistent worry about future attacks or maladaptive behavioral changes. Frequently associated with Agoraphobia (fear/avoidance of situations where escape might be difficult, e.g., crowds, public transit).
Social Anxiety Disorder (SAD / Social Phobia): Marked fear or anxiety about one or more social situations in which the individual may be scrutinized by others (e.g., public speaking, meeting new people), lasting ≥ 6 \ge 6 ≥ 6 months.
Specific Phobia: Marked, irrational fear of a specific object or situation (e.g., heights, animals, blood-injection-injury) lasting ≥ 6 \ge 6 ≥ 6 months.
Management Principles (CPA & CANMAT Guidelines)
Condition First-Line Pharmacotherapy Non-Pharmacological / Psychological First-Line Secondary / Adjunct Options
GAD SSRIs (Escitalopram, Sertraline); SNRIs (Duloxetine, Venlafaxine); Pregabalin Cognitive Behavioral Therapy (CBT) Buspirone, Hydroxyzine, Short-term Benzodiazepines
Panic Disorder SSRIs (Fluoxetine, Paroxetine, Sertraline); SNRIs (Venlafaxine) CBT with Interoceptive Exposure Short-term Benzodiazepines (e.g., Alprazolam, Clonazepam)
Social Anxiety SSRIs (Escitalopram, Paroxetine, Sertraline); SNRIs (Venlafaxine) CBT (Individual or Group) PRN Beta-Blockers (Propranolol 10-40 mg) for performance-only subtype
Specific Phobia Pharmacotherapy generally ineffective Exposure Therapy (Systematic desensitization / In vivo exposure) Short-term Benzodiazepine prior to infrequent triggers (e.g., flying)
CRITICAL EXAM TRAP: Avoid long-term Benzodiazepines for Anxiety Disorders. While benzodiazepines (e.g., lorazepam, alprazolam) offer rapid symptom relief, they carry significant risks of physiological tolerance, dependence, cognitive impairment, motor incoordination (fall risk in elderly), and rebound anxiety upon withdrawal. Use should be strictly limited to acute crises (1–2 weeks max).
- Obsessive-Compulsive Disorder (OCD)
- Diagnostic Criteria & Clinical Presentation
OCD is defined by the presence of obsessions , compulsions , or both:
Obsessions: Recurrent, persistent, intrusive, unwanted thoughts, urges, or images that cause marked anxiety or distress (e.g., contamination fears, doubts about locking doors, intrusive harm images). Obsessions are ego-dystonic (recognized by the patient as inconsistent with their personal values).
Compulsions: Repetitive behaviors (e.g., handwashing, checking, ordering) or mental acts (e.g., praying, counting) performed in response to an obsession to reduce anxiety or prevent a dreaded event.
Evidence-Based Treatment
First-Line Psychotherapy: Exposure and Response Prevention (ERP) — a specialized form of CBT where the patient is exposed to obsession triggers while refraining from performing compulsive rituals.
First-Line Pharmacotherapy: High-dose SSRIs (e.g., Sertraline, Fluoxetine, Fluvoxamine, Paroxetine). OCD typically requires higher doses of SSRIs than major depression (e.g., Sertraline up to 200–300 mg daily) and longer trial durations (8–12 weeks) to demonstrate therapeutic response.
Second-Line / Refractory: Clomipramine (a potent serotonergic Tricyclic Antidepressant; highly effective but limited by anticholinergic and cardiac side effects) or augmentation with low-dose atypical antipsychotics (Aripiprazole, Risperidone).
- Post-Traumatic Stress Disorder (PTSD) & Acute Stress Disorder (ASD)
- Trauma-Related Symptom Clusters
Both ASD and PTSD occur following exposure to actual or threatened death, serious injury, or sexual violence.
Four Core Symptom Clusters:
Intrusion: Re-experiencing memories, distressing dreams, flashbacks, or intense psychological reactivity to trauma cues.
Avoidance: Persistent avoidance of trauma-related thoughts, feelings, places, or people.
Negative Alterations in Cognition & Mood: Numbing, persistent negative beliefs about oneself/world, distorted blame, detachment, anhedonia.
Hyperarousal & Reactivity: Irritability, hypervigilance, exaggerated startle response, sleep disturbance, concentration deficits.
Timeline Distinction (High-Yield Exam Point)
Acute Stress Disorder (ASD): Symptoms present for 3 days to 1 month following trauma exposure.
Post-Traumatic Stress Disorder (PTSD): Symptoms persist for more than 1 month post-trauma and cause significant functional impairment.
Treatment Strategies
Psychotherapy: Trauma-focused CBT (Prolonged Exposure, Cognitive Processing Therapy) or Eye Movement Desensitization and Reprocessing (EMDR).
Pharmacotherapy: SSRIs (Sertraline, Paroxetine) or SNRIs (Venlafaxine) are first-line.
Nightmare Management: Prazosin (an alpha-1 adrenergic antagonist) effectively reduces PTSD-associated nightmares and sleep fragmentation by suppressing central sympathetic outflow.
Contraindication: Benzodiazepines are contraindicated in PTSD because they impair natural trauma processing, increase addiction risk, and worsen overall long-term outcomes.
Somatic Symptom & Related Disorders
Somatic symptom disorders involve prominent physical symptoms associated with significant distress and impairment, where psychological factors play a major role in onset or maintenance.
Disorder Core Clinical Features Key Diagnostic Clues Primary Management Strategy
Somatic Symptom Disorder One or more distressing somatic symptoms (e.g., chronic pain, fatigue) accompanied by disproportionate, persistent thoughts and anxiety about symptom seriousness. Symptoms are genuine and distressing to the patient; lasting ≥ 6 \ge 6 ≥ 6 months. Scheduled regular visits with single primary care physician; avoid unnecessary invasive tests; CBT.
Illness Anxiety Disorder Preoccupation with having or acquiring a serious, undiagnosed illness. Somatic symptoms are absent or minimal . High health anxiety. Patient performs excessive health-related checking or avoids doctors entirely ("hypochondriasis"). Empathic therapeutic alliance, CBT, SSRIs if co-morbid anxiety present.
Conversion Disorder (FNSD) One or more altered voluntary motor or sensory functions (e.g., blindness, paralysis, non-epileptic seizures). Clinical findings demonstrate clear incompatibility between symptom and recognized neuroanatomy (e.g., Hoover sign positive, normal EEG during seizure). Patient education on functional nature of symptoms, physical therapy, CBT. Do NOT accuse patient of faking.
Factitious Disorder Intentional falsification or induction of physical/psychiatric signs or symptoms. Primary motivation is to assume the sick role (internal secondary gain). No external reward. Non-confrontational communication, multidisciplinary team review, psychiatric consultation.
Malingering (Not a psychiatric illness) Intentional feigning or exaggeration of physical or psychological symptoms. Driven by external incentives (e.g., financial compensation, avoiding military duty/jail, obtaining controlled drugs). Document objective physical findings; firm, professional boundaries.